Table 2.
Baseline characteristics of the study population
| Variables | Mean ± SD or N (%) |
|---|---|
| Age, years | 66.1 ± 9.1 |
| Male sex | 6 (100.0) |
| Vascular access | |
| Native, graft | 5 (83.3), 1 (16.7) |
| Cause of ESRD | |
| ADPKD, HTN, diabetes | 2 (33.3), 1 (16.6), 3 (50.0) |
| Height, cm | 171.6 ± 4.9 |
| Dry weight, kg | 64.0 ± 8.3 |
| Volume distribution, L | 36.3 ± 3.4 |
| Urea reduction ratio, % | 72.3 ± 2.5 |
| UF volume, mL | |
| High-flux HD | 1833.3 ± 585.4 |
| Predilution OL-HDF | 1850.0 ± 634.8 |
| MCO HD | 2033.3 ± 436.7 |
| Dialysis vintage, years | 3.8 ± 1.8 |
| Residual urine level, L | 0.0 ± 0.0 |
| CRP level, mg/L | 2.1 ± 2.3 |
Data are expressed as means ± SDs or N (%)
SD standard deviation, ESRD end-stage renal disease, ADPKD autosomal dominant polycystic kidney disease, HTN hypertension, UF ultrafiltration, HD haemodialysis, OL-HDF online haemodiafiltration, MCO membrane cut-off, CRP C-reactive protein